Literature DB >> 35292292

Whole-Genome Sequencing Identifies Novel Heterozygous Mutation in ALMS1 in Three Men With Both Peyronie's and Dupuytren's Disease.

Alexandra Dullea1, Iakov Efimenko1, Fakiha Firdaus1, Anthony Griswold1, Himanshu Arora1, Thomas Masterson1, Ranjith Ramasamy2.   

Abstract

Peyronie's Disease (PD) is estimated to occur in up to 13% of males and has been associated with Dupuytren's Disease (DD). We identified 3 men with PD/DD and hypothesized that there may be a genetic association between the 2 diseases. Blood samples were collected from the participants and sent for whole genome sequencing. A rare non-synonymous mutation in the ALMS1 gene was identified in 3 men. Interestingly, ALMS1 is associated with TGF-b, and aberrant fibrosis. This pilot study generates the hypothesis that mutations in ALMS1 may predispose patients to development of PD/DD.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35292292      PMCID: PMC9356975          DOI: 10.1016/j.urology.2022.02.023

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.633


  15 in total

1.  The association between Peyronie's and Dupuytren's disease.

Authors:  H M Nugteren; J M Nijman; I J de Jong; M F van Driel
Journal:  Int J Impot Res       Date:  2011-06-02       Impact factor: 2.896

2.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data.

Authors:  Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo
Journal:  Genome Res       Date:  2010-07-19       Impact factor: 9.043

3.  Peyronie's Disease: AUA Guideline.

Authors:  Ajay Nehra; Ralph Alterowitz; Daniel J Culkin; Martha M Faraday; Lawrence S Hakim; Joel J Heidelbaugh; Mohit Khera; Erin Kirkby; Kevin T McVary; Martin M Miner; Christian J Nelson; Hossein Sadeghi-Nejad; Allen D Seftel; Alan W Shindel; Arthur L Burnett
Journal:  J Urol       Date:  2015-06-09       Impact factor: 7.450

4.  Peyronie's disease is associated with an increase in transforming growth factor-beta protein expression.

Authors:  A I El-Sakka; H M Hassoba; R J Pillarisetty; R Dahiya; T F Lue
Journal:  J Urol       Date:  1997-10       Impact factor: 7.450

5.  ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data.

Authors:  Kai Wang; Mingyao Li; Hakon Hakonarson
Journal:  Nucleic Acids Res       Date:  2010-07-03       Impact factor: 16.971

6.  The role of transforming growth factor beta in Dupuytren's disease.

Authors:  M A Badalamente; S P Sampson; L C Hurst; A Dowd; K Miyasaka
Journal:  J Hand Surg Am       Date:  1996-03       Impact factor: 2.230

Review 7.  Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up.

Authors:  Sultan Al-Thakafi; Naif Al-Hathal
Journal:  Transl Androl Urol       Date:  2016-06

8.  Characterization of Alstrom Syndrome 1 (ALMS1) Transcript Variants in Hodgkin Lymphoma Cells.

Authors:  Katarina Braune; Ines Volkmer; Martin S Staege
Journal:  PLoS One       Date:  2017-01-30       Impact factor: 3.240

Review 9.  ALMS1 and Alström syndrome: a recessive form of metabolic, neurosensory and cardiac deficits.

Authors:  Tom Hearn
Journal:  J Mol Med (Berl)       Date:  2018-11-12       Impact factor: 4.599

10.  ALMS1 Regulates TGF-β Signaling and Morphology of Primary Cilia.

Authors:  María Álvarez-Satta; Mauro Lago-Docampo; Brais Bea-Mascato; Carlos Solarat; Sheila Castro-Sánchez; Søren T Christensen; Diana Valverde
Journal:  Front Cell Dev Biol       Date:  2021-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.